Abstract | BACKGROUND: METHODS: Administrative data were analyzed from the Premier Healthcare Database, 2010-2014, in hospitalized stable patients with pulmonary embolism who received thrombolytic therapy and may or may not have received a vena cava filter. Patients were identified on the basis of International Classification of Disease, Ninth Revision, Clinical Modification codes. RESULTS: In-hospital all-cause mortality in stable patients who received a vena cava filter in addition to thrombolytic therapy was 139 of 2660 (5.2%), compared with 697 of 4332 (16.1%) who did not receive a filter (P < .0001) (relative risk .32). Mortality was lower with a filter every decade of age ≥ 31 years. CONCLUSION:
|
Authors | Paul D Stein, Fadi Matta, Mary J Hughes |
Journal | The American journal of medicine
(Am J Med)
Vol. 131
Issue 1
Pg. 97-99
(Jan 2018)
ISSN: 1555-7162 [Electronic] United States |
PMID | 28807710
(Publication Type: Journal Article)
|
Copyright | Copyright © 2018. Published by Elsevier Inc. |
Topics |
- Adult
- Aged
- Female
- Humans
- Male
- Middle Aged
- Pulmonary Embolism
(mortality, prevention & control)
- Retrospective Studies
- Thrombolytic Therapy
- Vena Cava Filters
|